Caricamento...

The Effect of Novel Therapies in High-Molecular-Risk Multiple Myeloma

Multiple myeloma is a heterogeneous disease with a prognosis that varies with patient factors, disease burden, tumor biology, and treatments. Certain molecular abnormalities confer a worse prognosis and thus are considered high-risk. These include t(4;14), del(17p), t(14;16), t(14;20), hypodiploidy,...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Adv Hematol Oncol
Autori principali: Lancman, Guido, Tremblay, Douglas, Barley, Kevin, Barlogie, Bart, Cho, Hearn Jay, Jagannath, Sundar, Madduri, Deepu, Moshier, Erin, Parekh, Samir, Chari, Ajai
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2017
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5993678/
https://ncbi.nlm.nih.gov/pubmed/29200420
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !